{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.text}}
How strategy, technology and ethics are coming together to address tomorrow's needs
The future of compliance in the pharmaceutical industry
Compliance in the pharmaceutical industry is being transformed by six key external forces: legal, financial, technological and medical innovation, cultural, educational and demographics.
PwC developed in collaboration with compliance leaders across the industry, the “Future of Compliance Whitepaper 2023” provides agenda-setting coverage about the issues, priorities and key challenges facing pharmaceutical compliance leaders as well as emerging trends, risks and business implications.
Download this free report to find out how compliance leaders can effectively plan for the future while successfully addressing their current business needs.
What’s inside:
✓ Understand today’s key challenges.
✓ Explore cases relating to business partner and healthcare professional interactions, the benefits to be achieved and the approaches taken.
✓ Get PwC recommendations for navigating the pharmaceutical compliance transformation programme.
{{filterContent.facetedTitle}}
{{contentList.loadingText}}
{{contentList.loadingText}}
Follow us
Contact us
Shaun Willcocks
Partner, Global Risk Markets Leader, Global Internal Audit Leader, PwC Japan
Tel: +81 (0)90 6478 6991
John Sabatini
Partner, Clients and Markets Leader, Cyber, Risk & Regulatory, PwC US
Tel: (646) 471-0335
Greg Unsworth
Partner, Digital and Data Services, Risk Services Leader, PwC Singapore
Tel: +65 9848 6025
Dr. Robert Paffen
Partner, Global Risk Services Digital Leader, Germany Risk & Regulatory Leader, PwC Germany
Rami Feghali
Partner, Global Risk Services FS Leader, Risk Services Leader, PwC France
Tel: +33 (0) 1 56 57 71 27
Darren Henderson
Partner, National Risk Assurance Leader and Finance Managed Services Leader, PwC Canada
Tel: +1 416 941 8379